Puretech Health PLC’s (PRTC) Buy Rating Reiterated at Peel Hunt

Puretech Health PLC (LON:PRTC)‘s stock had its “buy” rating reaffirmed by stock analysts at Peel Hunt in a report released on Tuesday. They currently have a GBX 278 ($3.67) target price on the stock. Peel Hunt’s price target suggests a potential upside of 118.25% from the company’s current price.

PRTC has been the topic of several other research reports. Numis Securities Ltd reiterated a “buy” rating and set a GBX 207 ($2.73) price target on shares of Puretech Health PLC in a research report on Monday, September 25th. Liberum Capital reiterated a “buy” rating and set a GBX 248 ($3.27) price target on shares of Puretech Health PLC in a research report on Wednesday, July 12th. Jefferies Group LLC reiterated a “buy” rating and set a GBX 225 ($2.97) price target on shares of Puretech Health PLC in a research report on Wednesday, August 30th. Finally, N+1 Singer reiterated a “buy” rating on shares of Puretech Health PLC in a research report on Monday, September 25th. Five equities research analysts have rated the stock with a buy rating, Puretech Health PLC presently has an average rating of “Buy” and an average price target of GBX 242.80 ($3.20).

Shares of Puretech Health PLC (LON:PRTC) opened at 127.375 on Tuesday. The firm’s market cap is GBX 301.06 million. The stock’s 50 day moving average is GBX 130.87 and its 200-day moving average is GBX 126.47. Puretech Health PLC has a one year low of GBX 110.00 and a one year high of GBX 139.00.

ILLEGAL ACTIVITY NOTICE: This report was first published by Community Financial News and is owned by of Community Financial News. If you are accessing this report on another website, it was illegally copied and reposted in violation of international trademark & copyright legislation. The original version of this report can be read at https://www.com-unik.info/2017/10/31/puretech-health-plcs-prtc-buy-rating-reiterated-at-peel-hunt.html.

Puretech Health PLC Company Profile

PureTech Health plc is a cross-disciplinary healthcare company. The Company operates through two segments: growth stage businesses and project phase businesses. Businesses in the growth stage businesses segment are those whose activities focus on developing products to solve healthcare problems in varied markets.

Analyst Recommendations for Puretech Health PLC (LON:PRTC)

What are top analysts saying about Puretech Health PLC? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Puretech Health PLC and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit